동향
동향 내용
Number of biosimilar investigational new drug applications (INDs) received in the month
분류 New Drug, IND 조회 2389
발행년도 2014 등록일 2015-07-27
출처 FDA (바로가기)
Biosimilar investigational new drug application refers to an investigation that FDA determines is intended to support a biosimilar biological product application for a product.

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies
다음글다음글 CDER New Drug Review